Praxis Precision Medicines PRAX Growth Metrics (2019-2026)

NASDAQ PRAX
$300.65 +1.78 (+0.60%)
At close: Sep 22, 2026 · 4:00 PM EDT
Reported Financials

Praxis Precision Medicines Quarterly Growth Metrics

Periods 27 quarters
Latest Jun 2026

Praxis Precision Medicines reported asset growth of 206.98% for the quarter ended Jun 2026. These growth metrics cover 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
171.36%-3.44%-14.23%-48.96%-57.80%-60.67%-58.92%-26.01%-22.04%-23.61%154.52%230.39%290.03%449.31%91.18%2.67%-4.77%94.14%205.01%206.98%
Assets Growth (3y)
34.14%-3.71%-33.80%-3.57%7.65%8.66%18.17%25.97%35.90%42.53%101.21%145.75%118.37%
Assets Growth (5y)
58.90%27.09%25.34%39.21%31.50%
Assets (QoQ)
-8.23%-9.76%-18.19%-24.67%-24.12%-15.90%-14.54%35.69%-20.05%-17.59%184.72%76.14%-5.62%16.06%-0.91%-5.41%-12.46%136.61%55.69%-4.80%
Capital Expenditures Growth (1y)Capex Growth (1y)
13,175.00%466.67%243.75%-89.68%11.11%-3.13%
Capital Expenditures Growth (3y)Capex Growth (3y)
-39.50%-29.62%
Capital Expenditures Growth (5y)Capex Growth (5y)
3.98%85.93%
Capital Expenditures (QoQ)Capex (QoQ)
1,262.50%21.79%-45.57%-61.94%-59.09%1,046.77%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
44.35%-53.24%-40.64%-68.14%-62.31%-55.58%3.83%121.81%61.89%31.95%88.00%16.77%66.83%164.91%8.94%8.46%-11.34%65.91%223.94%201.60%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
143.59%11.20%134.79%84.64%-4.14%-35.04%5.04%-6.20%0.59%15.80%28.60%41.10%33.79%79.66%87.90%56.32%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
108.11%36.88%92.61%51.46%5.43%3.80%32.54%21.97%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-5.80%-16.28%-43.87%-28.02%11.42%-1.32%31.20%53.76%-18.68%-19.57%86.94%-4.50%16.19%27.71%-23.13%-4.92%-5.01%138.97%50.10%-11.48%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
93.89%244.00%253.91%122.19%497.66%-85.67%-100.22%-368.29%-4,018.44%-21,736.00%44.02%109.13%1.71%-2,907.79%-574.20%-38.63%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
13.31%-100.72%54.08%-45.40%-81.43%-19.95%1.68%-154.76%-129.74%29.99%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-19.72%19.66%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
155.92%-24.95%-184.08%508.07%37.45%-52.88%50.48%-85.29%-182,340.00%-114.78%125.30%-122.03%-367.70%135.04%181.73%-751.40%-4.84%103.19%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-72.61%-121.76%-110.36%-90.61%-87.46%35.78%39.30%45.44%48.32%17.17%36.50%12.61%-18.46%-135.20%-154.16%-100.44%-136.57%-36.00%-62.52%-41.82%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-42.50%-56.50%-46.42%-18.70%-5.66%6.75%3.13%-4.70%-7.75%0.68%1.50%-13.14%-38.38%-37.91%-35.43%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-41.33%-43.97%-40.62%-36.20%-30.42%-27.35%-20.91%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
20.16%-87.20%-20.63%-5.73%21.48%35.87%-14.02%4.97%25.63%-2.78%12.59%-30.79%-0.81%-104.08%5.55%-3.14%-18.99%-17.32%-12.88%9.99%
EBITDA Margin Growth (1y)
-0.41M-0.60M-1.34M0.45M
EBITDA Margin (QoQ)
0.11M-0.10M0.01M-0.43M-0.08M-0.83M1.80M
EBIT Growth (1y)
-176.09%-128.13%-151.10%-65.54%1.08%29.33%44.67%42.11%42.39%32.92%-9.96%-7.23%-122.74%-130.01%-78.41%-102.91%-37.87%-51.74%-41.66%-27.39%
EBIT Growth (3y)
-60.79%-76.85%-65.07%-44.57%-16.31%-2.64%-15.17%-0.91%-8.28%-2.92%-2.77%-7.99%-20.95%-32.78%-40.59%-40.47%
EBIT Growth (5y)
-39.77%-53.54%-54.57%-45.74%-37.03%-30.43%-31.02%-21.58%
EBIT Margin Growth (1y)
-0.41M-0.60M-1.34M0.45M
EBIT Margin (QoQ)
0.11M-0.10M0.01M-0.43M-0.08M-0.83M1.80M
EBIT (QoQ)
-22.72%-31.01%-17.38%12.28%26.66%6.41%8.11%8.22%27.01%-8.97%-50.64%10.50%-51.61%-12.53%-16.84%-1.79%-3.01%-23.85%-9.08%8.46%
EBT Growth (1y)
-175.65%-127.91%-153.09%-66.12%1.69%31.49%45.24%42.22%41.94%30.72%-10.40%-7.50%-117.25%-130.01%-78.41%-103.21%-41.36%-51.74%-44.56%-28.36%
EBT Growth (3y)
-60.61%-75.13%-65.68%-44.57%-16.31%-2.65%-15.23%-1.05%-7.44%-2.97%-2.55%-8.07%-21.26%-34.22%-41.73%-41.02%
EBT Growth (5y)
-39.20%-53.63%-55.04%-45.85%-37.03%-30.43%-31.59%-21.90%
EBT Margin Growth (1y)
-0.42M-0.60M-1.29M0.45M
EBT Margin (QoQ)
0.11M-0.10M0.01M-0.43M-0.08M-0.78M1.75M
EBT (QoQ)
-22.80%-31.07%-18.25%12.72%27.33%8.67%5.48%7.90%26.97%-8.97%-50.63%10.32%-47.58%-15.38%-16.84%-2.15%-2.66%-23.85%-11.31%9.29%
EPS (Basic) Growth (1y)
91.74%53.67%-114.20%-51.63%3.98%36.90%53.13%62.27%80.40%67.71%71.89%73.45%-3.99%15.30%-17.81%-78.13%-21.47%-20.73%-5.38%5.37%
EPS (Basic) Growth (3y)
49.85%47.32%51.01%60.75%75.04%54.47%34.40%46.64%41.94%44.33%46.26%43.70%37.21%30.88%29.59%23.51%
EPS (Basic) Growth (5y)
51.91%47.47%47.75%50.88%54.43%37.35%18.92%23.85%
EPS (Basic) (QoQ)
-14.17%-38.02%-10.45%12.89%27.69%9.31%17.95%29.87%62.44%-49.39%28.56%33.76%-47.11%-21.68%0.64%-0.16%-0.31%-20.94%13.27%10.06%
EPS (Diluted) Growth (1y)
91.74%53.67%-114.20%-51.63%3.98%36.90%53.13%62.27%80.40%67.71%71.89%73.45%-3.99%15.30%-17.81%-78.13%-21.47%-20.73%-5.38%5.37%
EPS (Diluted) Growth (3y)
60.75%75.04%54.47%34.40%46.64%41.94%44.33%46.26%43.70%37.21%30.88%29.59%23.51%
EPS (Diluted) Growth (5y)
50.88%54.43%37.35%18.92%23.85%
EPS (Diluted) (QoQ)
-14.17%-38.02%-10.45%12.89%27.69%9.31%17.95%29.87%62.44%-49.39%28.56%33.76%-47.11%-21.68%0.64%-0.16%-0.31%-20.94%13.27%10.06%
FCF Margin Growth (1y)
-0.00M-0.36M-0.41M0.39M
FCF Margin (QoQ)
0.08M-0.10M0.03M-0.02M-0.28M-0.15M0.84M
Free Cash Flow Growth (1y)FCF Growth (1y)
-75.75%-124.34%-111.07%-90.78%-84.29%36.53%39.62%45.54%48.26%17.17%36.50%12.61%-18.20%-135.20%-154.47%-100.44%-136.54%-36.00%-62.44%-43.12%
Free Cash Flow Growth (3y)FCF Growth (3y)
-42.50%-56.50%-46.42%-18.78%-5.65%6.81%3.17%-4.07%-7.33%0.82%1.56%-13.10%-38.38%-37.94%-35.85%
Free Cash Flow Growth (5y)FCF Growth (5y)
-41.33%-44.01%-40.62%-36.19%-30.41%-27.32%-21.10%
Free Cash Flow (QoQ)FCF (QoQ)
18.80%-86.03%-19.85%-5.37%21.55%35.94%-14.02%4.97%25.47%-2.56%12.59%-30.79%-0.81%-104.08%5.43%-3.02%-18.97%-17.33%-12.96%9.23%
Net Cash Flow Growth (1y)NCF Growth (1y)
-110.73%-114.83%62.86%-148.32%162.75%96.94%131.28%299.23%-462.68%-2,298.18%267.67%-115.73%201.24%336.17%-170.47%-19.23%-133.56%344.72%459.41%-660.40%
Net Cash Flow Growth (3y)NCF Growth (3y)
-26.42%35.69%47.65%-30.93%-28.24%34.39%-29.10%62.67%55.12%6.76%27.97%-47.86%533.20%110.38%-50.76%
Net Cash Flow Growth (5y)NCF Growth (5y)
2.90%-5.25%-21.09%-15.81%2.71%25.25%-27.53%
Net Cash Flow (QoQ)NCF (QoQ)
-122.59%-164.46%-127.80%64.50%129.34%-112.89%2,430.18%126.08%-153.42%14.77%457.24%-109.67%443.75%98.82%-206.59%83.63%3.24%2,734.41%-13.86%-134.63%
Net Income Growth (1y)
-175.68%-127.89%-153.09%-66.12%1.70%31.49%45.24%42.22%41.94%30.72%-10.40%-7.50%-117.25%-130.01%-78.41%-103.21%-41.36%-51.74%-44.56%-28.36%
Net Income Growth (3y)
-60.61%-75.13%-65.76%-44.55%-16.31%-2.65%-15.23%-1.05%-7.43%-2.97%-2.55%-8.07%-21.26%-34.22%-41.73%-41.02%
Net Income Growth (5y)
-39.20%-53.63%-55.08%-45.84%-37.03%-30.43%-31.59%-21.90%
Net Income (QoQ)
-22.81%-31.04%-18.26%12.72%27.33%8.67%5.48%7.90%26.97%-8.97%-50.63%10.32%-47.58%-15.38%-16.84%-2.15%-2.66%-23.85%-11.31%9.29%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-121.76%-119.77%-153.09%-66.12%1.70%31.49%45.24%42.22%41.94%30.72%-10.40%-7.50%-117.25%-130.01%-78.41%-103.21%-41.36%-51.74%-44.56%-28.36%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-54.69%-63.95%-56.48%-36.94%-8.17%-1.42%-15.23%-1.05%-7.43%-2.97%-2.55%-8.07%-21.26%-34.22%-41.73%-41.02%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-36.09%-47.67%-49.81%-41.18%-31.20%-29.49%-31.59%-21.90%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-22.81%-31.04%-18.26%12.72%27.33%8.67%5.48%7.90%26.97%-8.97%-50.63%10.32%-47.58%-15.38%-16.84%-2.15%-2.66%-23.85%-11.31%9.29%
Net Margin Growth (1y)
-0.42M-0.60M-1.29M0.45M
Net Margin (QoQ)
0.11M-0.10M0.01M-0.43M-0.08M-0.78M1.75M
Operating Income Growth (1y)Op. Inc Growth (1y)
-176.09%-128.13%-151.10%-65.54%1.08%29.33%44.67%42.11%42.39%32.92%-9.96%-7.23%-122.74%-130.01%-78.41%-102.91%-37.87%-51.74%-41.66%-27.39%
Operating Income Growth (3y)Op. Inc Growth (3y)
-60.79%-76.85%-65.07%-44.57%-16.31%-2.64%-15.17%-0.91%-8.28%-2.92%-2.77%-7.99%-20.95%-32.78%-40.59%-40.47%
Operating Income Growth (5y)Op. Inc Growth (5y)
-39.77%-53.54%-54.57%-45.74%-37.03%-30.43%-31.02%-21.58%
Operating Income (QoQ)Op. Inc (QoQ)
-22.72%-31.01%-17.38%12.28%26.66%6.41%8.11%8.22%27.01%-8.97%-50.64%10.50%-51.61%-12.53%-16.84%-1.79%-3.01%-23.85%-9.08%8.46%
Operating Margin Growth (1y)
-0.41M-0.60M-1.34M0.45M
Operating Margin (QoQ)
0.11M-0.10M0.01M-0.43M-0.08M-0.83M1.80M
Profit After Tax Growth (1y)PAT Growth (1y)
-175.68%-127.89%-151.04%-65.36%1.70%29.72%45.49%43.00%43.95%34.72%-5.60%4.77%-110.74%-118.32%-75.20%-118.47%-42.43%-51.50%-33.57%-18.78%
Profit After Tax Growth (3y)PAT Growth (3y)
-60.61%-77.29%-65.05%-43.68%-14.95%-1.50%-13.05%3.53%-5.11%-0.06%-0.28%-5.85%-18.94%-29.25%-35.20%-35.20%
Profit After Tax Growth (5y)PAT Growth (5y)
-37.39%-51.35%-52.76%-43.91%-35.45%-28.17%-27.59%-18.43%
Profit After Tax (QoQ)PAT (QoQ)
-22.81%-31.04%-17.30%12.40%26.99%6.31%9.03%8.39%28.21%-9.12%-47.16%17.38%-58.86%-13.04%-18.09%-3.02%-3.56%-20.24%-4.12%8.39%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
537.76%1,379.27%947.71%523.08%72.32%-19.95%-24.26%-33.07%-35.00%-39.44%-44.97%-51.38%-60.43%-60.88%-48.11%-30.08%-37.18%-36.09%-31.17%90.70%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
96.49%92.59%92.84%63.45%26.57%-23.76%-42.55%-39.97%-38.95%-45.54%-46.70%-41.86%-13.46%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
12.44%12.17%12.38%9.30%22.01%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
243.41%94.08%-5.85%-0.70%-5.03%-9.84%-10.92%-12.25%-7.77%-16.00%-19.05%-22.48%-24.93%-16.97%7.39%4.45%-32.56%-15.52%15.65%189.41%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.00M-0.00M-0.00M-472.000.00M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.01M-0.00M-499.00164.00992.000.00M0.01M0.01M0.01M0.01M0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.00M-224.00665.00
Return on Assets [ROA] (QoQ)ROA (QoQ)
-618.00-0.00M-0.00M-0.00M-0.00M-0.00M-125.000.00M0.00M-0.00M0.01M0.00M45.00-626.00-396.00-989.00-0.00M0.00M0.00M324.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.00M-0.01M-0.01M-0.01M-0.02M-0.01M-0.00M0.00M0.01M0.02M0.01M0.01M0.01M0.00M-0.00M-0.00M-514.000.00M0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.01M-0.01M-561.00133.000.00M0.00M0.01M0.01M0.02M0.02M0.01M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-0.00M-194.00773.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-756.00-0.00M-0.00M-0.00M-0.00M-0.01M-524.000.01M0.00M-0.00M0.01M0.00M-62.00-713.00-422.00-0.00M-0.00M0.00M0.00M362.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.41M-0.60M-1.34M0.45M0.68M0.70M1.49M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.11M-0.10M0.01M-0.43M-0.08M-0.83M1.80M-0.20M-0.06M-0.04M
Revenue Growth (1y)
-36.90%-54.29%-35.47%1,349.13%
Revenue (QoQ)
14.35%-40.08%10.04%-16.31%-17.17%-15.41%2,371.19%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
584.26%59.59%69.01%40.94%3.21%4.26%-3.72%-24.12%-14.37%-10.05%90.64%1.78%115.72%49.76%-39.30%32.19%-40.10%15.90%94.76%45.55%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
272.42%172.63%82.19%14.38%45.84%2.87%24.00%11.98%3.67%0.69%3.43%16.01%31.11%25.11%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
126.62%93.69%50.86%21.03%29.68%15.93%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
20.76%-6.36%29.15%-3.49%-11.58%-5.41%19.27%-23.94%-0.21%-0.64%152.79%-59.39%111.50%-31.02%2.46%-11.56%-4.16%33.45%72.19%-33.91%
Tax Rate (QoQ)
2.00

Praxis Precision Medicines Growth Metrics API

Pull Praxis Precision Medicines's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PRAX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY